Company profile
NIKA PHARMACEUTICALS, INC CIK 1145604
Ticker
NIKA (OTC)
Industry
Pharmaceutical Preparations
Headquarters
Henderson, NV 89044
Fiscal year end
2025 (FY)
Key Financials
Revenue
—
Net income
-$76.4K
Total assets
$21.0K
Total liabilities
$318.6K
Stockholders' equity
-$297.6K
Cash & equivalents
$1.9K
Operating income
-$76.4K
Operating cash flow
-$79.7K
Capital expenditures
—
Fiscal year 2025, via 10-K filed 2026-03-25. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.
Financial Performance
Operating margin
—
Net margin
—
Free cash flow
—
Free cash flow margin
—
Liabilities / assets
1,517.5%
Equity / assets
-1,417.5%
CapEx / revenue
—
Operating cash flow / net income
1.04×
Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.
Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025
—
-$76.4K
$21.0K
$318.6K
-$297.6K
2024
$0
-$95.8K
$17.9K
$239.2K
-$221.2K
2023
$0
-$64.8K
$19.6K
$101.7K
-$82.1K
2022
$0
-$3.18M
$864
$18.2K
-$17.3K
2021
$0
-$14.7K
$399
$24.0K
-$23.6K
Company Details
SIC code
2834
State of incorporation
CO
Active filer
Yes
Most recent SEC filing
Form 10-Q
2026-08-10
Financials filed via
Form 10-K
filed 2026-03-25
"Most recent SEC filing" may differ from the filing used for the financial figures above.
Location
Henderson, NV 89044
Data & Methodology
SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:38 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.